doi: 10.1021/jm031147e.
Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations
Affiliations
- PMID: 15239667
- DOI: 10.1021/jm031147e
Item in Clipboard
Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations
J Med Chem.
.
Erratum in
- J Med Chem. 2004 Oct 21;47(22):5592
Abstract
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) active against NNRTI-resistant mutants were obtained by introducing two methyl groups at positions 3 and 5 of the benzenesulfonyl moiety of L-737,126 (1) and coupling one to three glycinamide/alaninamide units to its carboxyamide function. In cell-based assays, the new derivatives showed activities against HIV-1 wild type and NNRTI-resistant mutants [Y181C, K103N-Y181C, and triple mutant (K103R, V179D, P225H) highly resistant to efavirenz] superior to that of the parent indole derivative 1.
Similar articles
-
Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies.J Med Chem. 2003 Jun 5;46(12):2482-93. doi: 10.1021/jm0211063. J Med Chem. 2003. PMID: 12773052
-
Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.J Med Chem. 2007 Oct 4;50(20):5034-8. doi: 10.1021/jm070488f. Epub 2007 Sep 6. J Med Chem. 2007. PMID: 17803291
-
Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus.J Med Chem. 2009 Apr 9;52(7):1922-34. doi: 10.1021/jm801470b. J Med Chem. 2009. PMID: 19281225
-
IDX-899, an aryl phosphinate-indole non-nucleoside reverse transcriptase inhibitor for the potential treatment of HIV infection.Curr Opin Investig Drugs. 2010 Feb;11(2):237-45. Curr Opin Investig Drugs. 2010. PMID: 20112173 Review.
-
HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.AIDS Rev. 2009 Jul-Sep;11(3):165-73. AIDS Rev. 2009. PMID: 19654858 Review.
Cited by
-
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.J Acquir Immune Defic Syndr. 2010 Sep;55(1):132-4. doi: 10.1097/QAI.0b013e3181d5a800. J Acquir Immune Defic Syndr. 2010. PMID: 20733405 Free PMC article. No abstract available.
-
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.Molecules. 2016 Feb 16;21(2):221. doi: 10.3390/molecules21020221. Molecules. 2016. PMID: 26891289 Free PMC article. Review.
-
High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzyme.Antimicrob Agents Chemother. 2005 Nov;49(11):4546-54. doi: 10.1128/AAC.49.11.4546-4554.2005. Antimicrob Agents Chemother. 2005. PMID: 16251294 Free PMC article.
-
Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.ACS Med Chem Lett. 2012 May 2;3(6):470-5. doi: 10.1021/ml3000462. eCollection 2012 Jun 14. ACS Med Chem Lett. 2012. PMID: 24900496 Free PMC article.
-
Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.Antivir Chem Chemother. 2018 Jan-Dec;26:2040206617753443. doi: 10.1177/2040206617753443. Antivir Chem Chemother. 2018. PMID: 29417826 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
